Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Molecular Oncology|February 5, 2019
Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferationRuoxi Hong, Weimin Zhang, Xi Xia, et al.
Drug Design, Development and Therapy|August 19, 2021
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with EverolimusFangfang Duan, Chenge Song, Yuyu Ma, et al.
Journal of Oncology|October 17, 2022
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort StudyYuyu Ma, Fangfang Duan, Yue Zhuang, et al.
Molecular Cancer|August 23, 2018
The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironmentWeimin Zhang, Ruoxi Hong, Lin Li, et al.
Breast (Edinburgh, Scotland)|June 19, 2024
Clinicopathological characteristics and genomic profiling of pure mucinous breast cancerQianyi Lu, Hanxing Zhou, Jianwei Zhang, et al.
Cancer Letters|January 25, 2019
CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancerKai Zhang, Ruoxi Hong, Lee Kaping, et al.
The Oncologist|February 15, 2020
Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II StudyFei Xu, Kaping Lee, Wen Xia, et al.
NPJ Breast Cancer|November 7, 2025
Real-world outcomes of trastuzumab deruxtecan in HR-negative HER2-low metastatic breast cancerMengqian Ni, Daining Wang, Shu Dun, et al.
Nature Communications|May 3, 2025
Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategyDongshao Chen, Zitong Zhao, Ruoxi Hong, et al.
Breast Cancer Research and Treatment|November 5, 2018
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancerCong Xue, Wenwen Wei, Peng Sun, et al.
Pageof 6